Digitale Bibliotheek
Sluiten Bladeren door artikelen uit een tijdschrift
     Tijdschrift beschrijving
       Alle jaargangen van het bijbehorende tijdschrift
         Alle afleveringen van het bijbehorende jaargang
                                       Alle artikelen van de bijbehorende aflevering
 
                             48 gevonden resultaten
nr titel auteur tijdschrift jaar jaarg. afl. pagina('s) type
1 Adjuvants that stimulate TLR3 or NLPR3 pathways enhance the efficiency of influenza virus-like particle vaccines in aged mice Schneider-Ohrum, Kirsten
2011
29 48 p. 9081-9092
12 p.
artikel
2 A phase III randomized, controlled study to assess and compare the immunogenicity and tolerability of single and multi-dose vials of DTwP-Hib, a fully liquid quadravalent vaccine and their comparison with TETRAct-Hib vaccine in Indian infants aged 6–14 weeks Sharma, Hitt
2011
29 48 p. 8773-8779
7 p.
artikel
3 A phase I randomized, double-blind, controlled trial of 2009 influenza A (H1N1) inactivated monovalent vaccines with different adjuvant systems Precioso, Alexander R.
2011
29 48 p. 8974-8981
8 p.
artikel
4 A systematic review of intradermal influenza vaccines Young, Flora
2011
29 48 p. 8788-8801
14 p.
artikel
5 Attenuation of bovine herpesvirus type 1 by deletion of its glycoprotein G and tk genes and protection against virulent viral challenge Zhang, Minmin
2011
29 48 p. 8943-8950
8 p.
artikel
6 Blood stage merozoite surface protein conjugated to nanoparticles induce potent parasite inhibitory antibodies Pusic, Kae
2011
29 48 p. 8898-8908
11 p.
artikel
7 Borrelia burgdorferi BBA52 is a potential target for transmission blocking Lyme disease vaccine Kumar, Manish
2011
29 48 p. 9012-9019
8 p.
artikel
8 Building on the success of the Expanded Programme on Immunization: Enhancing the focus on disease prevention and control John, T.J.
2011
29 48 p. 8835-8837
3 p.
artikel
9 Cancer vaccines and carbohydrate epitopes Heimburg-Molinaro, Jamie
2011
29 48 p. 8802-8826
25 p.
artikel
10 Changes in serotype distribution of Haemophilus influenzae meningitis isolates identified through laboratory-based surveillance following routine childhood vaccination against H. influenzae type b in Brazil Zanella, Rosemeire C.
2011
29 48 p. 8937-8942
6 p.
artikel
11 Characterization of the interactions of the pneumolysoid, Δ6 PLY, with human neutrophils in vitro Cockeran, R.
2011
29 48 p. 8780-8782
3 p.
artikel
12 Clonal replacement among 19A Streptococcus pneumoniae in Massachusetts, prior to 13 valent conjugate vaccination Hanage, W.P.
2011
29 48 p. 8877-8881
5 p.
artikel
13 Comparing live attenuated and inactivated hepatitis A vaccines: An immunogenicity study after one single dose Zheng, Hui
2011
29 48 p. 9098-9103
6 p.
artikel
14 Construction of a non-toxigenic Escherichia coli oral vaccine strain expressing large amounts of CS6 and inducing strong intestinal and serum anti-CS6 antibody responses in mice Tobias, Joshua
2011
29 48 p. 8863-8869
7 p.
artikel
15 Development and characterization of chitosan coated poly-(ε-caprolactone) nanoparticulate system for effective immunization against influenza Gupta, Nand Kishore
2011
29 48 p. 9026-9037
12 p.
artikel
16 Distinct immunoregulatory properties of macrophage migration inhibitory factors encoded by Eimeria parasites and their chicken host Jang, Seung I.
2011
29 48 p. 8998-9004
7 p.
artikel
17 Do the initial serum level changes of sCD26 have ability to predict successful treatment with IFN-α among naïve chronic hepatitis B patients? Alavi-Moghaddam, Mostafa
2011
29 48 p. 9093-9097
5 p.
artikel
18 Dynamics of Streptococcus pneumoniae nasopharyngeal carriage with high heptavalent pneumococcal conjugate vaccine coverage in Central Greece Grivea, Ioanna N.
2011
29 48 p. 8882-8887
6 p.
artikel
19 Editorial Board/Aims and Scope 2011
29 48 p. CO2-
1 p.
artikel
20 Effectiveness of 7-valent pneumococcal conjugate vaccine in the prevention of invasive pneumococcal disease in children aged 7–59 months. A matched case-control study Domínguez, Angela
2011
29 48 p. 9020-9025
6 p.
artikel
21 Enhanced immune sera and vaccine: Safe approach to treat scorpion envenoming Lila, Boussag-Abib
2011
29 48 p. 8951-8959
9 p.
artikel
22 Genetic polymorphisms in host antiviral genes: Associations with humoral and cellular immunity to measles vaccine Haralambieva, Iana H.
2011
29 48 p. 8988-8997
10 p.
artikel
23 Immunization with the RTS,S/AS malaria vaccine induces IFN-γ +CD4 T cells that recognize only discrete regions of the circumsporozoite protein and these specificities are maintained following booster immunizations and challenge Schwenk, Robert
2011
29 48 p. 8847-8854
8 p.
artikel
24 Immunogenicity and tolerability of a paediatric presentation of a virosomal hepatitis A vaccine in Chilean children aged 1–16 years Abarca, Katia
2011
29 48 p. 8855-8862
8 p.
artikel
25 Immunogenicity of novel nanoparticle-coated MSP-1 C-terminus malaria DNA vaccine using different routes of administration Cherif, Mahamoud Sama
2011
29 48 p. 9038-9050
13 p.
artikel
26 Immunological responses induced by a DNA vaccine expressing RON4 and by immunogenic recombinant protein RON4 failed to protect mice against chronic toxoplasmosis Rashid, Imran
2011
29 48 p. 8838-8846
9 p.
artikel
27 Impact of Vi vaccination on spatial patterns of typhoid fever in the slums of Kolkata, India Ali, Mohammad
2011
29 48 p. 9051-9056
6 p.
artikel
28 Improved immune responses in mice using the novel chitosan adjuvant ViscoGel, with a Haemophilus influenzae type b glycoconjugate vaccine Neimert-Andersson, Theresa
2011
29 48 p. 8965-8973
9 p.
artikel
29 Improving immunogenicity of HIV-1 envelope gp120 by glycan removal and immune complex formation Kumar, Rajnish
2011
29 48 p. 9064-9074
11 p.
artikel
30 Inflammatory responses to trivalent influenza virus vaccine among pregnant women Christian, Lisa M.
2011
29 48 p. 8982-8987
6 p.
artikel
31 Influenza associated mortality in the subtropics and tropics: Results from three Asian cities Yang, Lin
2011
29 48 p. 8909-8914
6 p.
artikel
32 Leishmania major MAP kinase 10 is protective against experimental L. major infection Kumari, Sangeeta
2011
29 48 p. 8783-8787
5 p.
artikel
33 “Once I begin to participate, people will run away from me”: Understanding stigma as a barrier to HIV vaccine research participation in Kenya Nyblade, Laura
2011
29 48 p. 8924-8928
5 p.
artikel
34 Perspective of the U.S. Food and Drug Administration on concomitant administration of Zostavax and Pneumovax Baylor, Norman W.
2011
29 48 p. 8771-
1 p.
artikel
35 Pre-clinical evaluation of a 15-valent pneumococcal conjugate vaccine (PCV15-CRM197) in an infant-rhesus monkey immunogenicity model Skinner, Julie M.
2011
29 48 p. 8870-8876
7 p.
artikel
36 Preparing for the next public debate: Universal vaccination against hepatitis B Houweling, Hans
2011
29 48 p. 8960-8964
5 p.
artikel
37 Quantitative analysis of neutralizing antibody response to human cytomegalovirus in natural infection Wang, Dai
2011
29 48 p. 9075-9080
6 p.
artikel
38 Response to Dr. Norman W. Baylor's Letter to the Editor entitled: “Perspective of the U.S. Food and Drug Administration on Concomitant Administration of Zostavax and Pneumovax” Oxman, Michael N.
2011
29 48 p. 8772-
1 p.
artikel
39 Rubella vaccines: WHO position paper—Recommendations WHO Publication,
2011
29 48 p. 8767-8768
2 p.
artikel
40 Safe landing for global polio eradication: A perspective Arita, Isao
2011
29 48 p. 8827-8834
8 p.
artikel
41 The antitumor immunopreventive effects of a DNA vaccine against CYP26a1 on mouse breast carcinoma Wang, Rong-Chun
2011
29 48 p. 8915-8923
9 p.
artikel
42 The clinical benefit and cost-effectiveness of human papillomavirus vaccination for adult women in the Netherlands Bogaards, Johannes A.
2011
29 48 p. 8929-8936
8 p.
artikel
43 The cost-effectiveness of rotavirus vaccination in Armenia Jit, Mark
2011
29 48 p. 9104-9111
8 p.
artikel
44 The predicted impact of HPV vaccination on male infections and male HPV-related cancers in Australia Smith, Megan A.
2011
29 48 p. 9112-9122
11 p.
artikel
45 The recombinant gut-associated M17 leucine aminopeptidase in combination with different adjuvants confers a high level of protection against Fasciola hepatica infection in sheep Maggioli, Gabriela
2011
29 48 p. 9057-9063
7 p.
artikel
46 Vaccination with drifted variants of avian H5 hemagglutinin protein elicits a broadened antibody response that is protective against challenge with homologous or drifted live H5 influenza virus Santiago, Felix W.
2011
29 48 p. 8888-8897
10 p.
artikel
47 Vaccine effectiveness for laboratory-confirmed influenza in children 6–59 months of age, 2005–2007 Staat, Mary Allen
2011
29 48 p. 9005-9011
7 p.
artikel
48 Vaccines against tick-borne encephalitis: WHO position paper – Recommendations WHO Publication,
2011
29 48 p. 8769-8770
2 p.
artikel
                             48 gevonden resultaten
 
 Koninklijke Bibliotheek - Nationale Bibliotheek van Nederland